|
Adherence
to HAART in the Homeless Population in San Francisco: 31% in Study
Discontinued Therapy
Researchers
ant UCSF and Stanford University examined adherence to HAART
among the homeless, a population thought to be
at high risk for poor adherence to therapy
and for development of drug-resistant strains of
HIV.
They
performed a 12-month prospective study of 148 persons
receiving HAART who were identified in a stratified
screening of the homeless and marginally housed.
They
sampled in lunch lines, shelters, and hotels in
3 neighborhoods of San Francisco, California. They used
pill counts at unannounced home visits as the
primary measure of adherence.
Results
Of
148 individuals sampled, 46 (31%) discontinued HAART
during the study.
Average
adherence in the group of those who discontinued
HAART was 51%, and 9% of these subjects had
undetectable virus loads (i.e., <400 copies/mL) at
the last follow-up visit.
Predictors
of discontinuation of therapy were depressive
symptoms, injection
drug use, African
American ethnicity, and early poor
adherence.
Of
148 subjects, 102 (69%) continued to receive
HAART throughout the study period.
Average
adherence in the group of those who continued
to receive HAART was 74%, and 55% of these
subjects had undetectable virus loads at the last
follow-up visit.
Predictors
of lower average adherence in this group were
African American ethnicity and use of crack cocaine;
men who had sex with men had higher adherence.
Conclusions
The
authors conclude, “One-third of homeless and marginally
housed persons receiving HAART discontinued therapy during
the follow-up period and would benefit from adherence
interventions directed at sustaining therapy; two-thirds
continued to receive therapy at adherence levels
comparable to those found with other clinical populations.”
Departments of Epidemiology and Biostatistics
and Medicine, University of
California, San Francisco, and
Department of Medicine, Stanford
University Medical Center, Stanford,
California.
10/04/04
Reference
A R Moss
and others. Adherence to Highly Active
Antiretroviral Therapy in the
Homeless Population in San
Francisco: A Prospective Study.
Clinical Infectious Diseases 39(8): 1190-1198. October 15,
2004.
|